David J Apple Laboratory for Vision Research, Heidelberg, Germany.
Reprint requests: Gerd U. Auffarth, MD, PhD, University Eye Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany; e-mail: [email protected]
G. U. Auffarth reports grants, personal fees, nonfinancial support and consulting fees from Johnson & Johnson and Alcon; grants, personal fees, and nonfinancial support from Carl Zeiss Meditec, Hoya, Kowa, Oculentis/Teleon, Rayner, Santen, Sifi, and Ursa-pharm; grants and personal fees from Biotech and Oculus, EyeYon; grants from Acufocus, Conta-mac, Glaukos, Physiol, and Rheacell, outside the submitted work. R. Khoramnia reports grants, personal fees, and nonfinancial support from Alcon, Johnson & Johnson, Hoya, Physiol, and Rayner; personal fees and nonfinancial support from Kowa, Ophtec, Oculentis/Teleon, Santen, and Acufocus, outside the submitted work.
This study was made possible through the support of the Klaus Tschira Foundation granted to GUA. The funding organization had no role in the design or conduct of this research.
None of the authors have any conflicting interests to disclose.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.retinajournal.com).
